CSI Market
Sign In | Register

Syndax Pharmaceuticals Inc (SNDX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SNDX Annual Balance Sheets →
The balance sheet data below highlights changes in Syndax Pharmaceuticals Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SNDX/balance-sheets
https://api.csimarket.com/api/v1/companies/SNDX/fundamentals
https://api.csimarket.com/api/v1/companies/SNDX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent135.94
Short-term Investments, Total0.00
Deposits Assets, Current AS10.15
Cash & Short-term Investments145.00
Accounts receivable46.87
Other Receivables3.70
Notes Receivable, Current3.07
Inventories39.38
Other Current Assets0.00
Prepaid Expense And Other Assets Current18.67
Total Current Assets567.44
Equipment/Property/Plant Net0.65
Long-term investments123.98
Deferred, Prepaid and Other Assets, Noncurrent5.91
Other Assets, Noncurrent304.38
Operating Lease Right Of Use Asset1.21
Total Assets692.67
Liabilities
Accounts Payable, Current AC3.57
Accrued Liabilities And Other Liabilities14.17
Loans Payable to Bank, Current LO1344.10
Other Liabilities, Current0.00
Total Current Liabilities120.96
Long-term Debt Convertible244.19
Total Long-term Debt244.19
Other liabilities, Noncurrent103.83
Total Liabilities709.85
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,632.53
Retained Earnings / Accumulated Deficit-1,648.05
Accumulated Other Comprehensive Income-1.67
Other Equity0.00
Common Stockholder's Equity-17.18
Total Stockholder's Equity-17.18
Liabilities & Stockholder's Equity692.67
4 historic quarters locked

Sign in to unlock the full Syndax Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Syndax Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-443625

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI